-+ 0.00%
-+ 0.00%
-+ 0.00%

BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.

Zhitongcaijing·12/07/2025 03:25:00
Listen to the news
BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.